chr14-92071035-T-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7

The NM_004993.6(ATXN3):​c.891A>G​(p.Gln297Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 2 hom., cov: 0)
Exomes 𝑓: 0.19 ( 273 hom. )
Failed GnomAD Quality Control

Consequence

ATXN3
NM_004993.6 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.273

Publications

18 publications found
Variant links:
Genes affected
ATXN3 (HGNC:7106): (ataxin 3) Machado-Joseph disease, also known as spinocerebellar ataxia-3, is an autosomal dominant neurologic disorder. The protein encoded by this gene contains (CAG)n repeats in the coding region, and the expansion of these repeats from the normal 12-44 to 52-86 is one cause of Machado-Joseph disease. There is a negative correlation between the age of onset and CAG repeat numbers. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2016]
ATXN3 Gene-Disease associations (from GenCC):
  • Machado-Joseph disease
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • Machado-Joseph disease type 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Machado-Joseph disease type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Machado-Joseph disease type 3
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 14-92071035-T-C is Benign according to our data. Variant chr14-92071035-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 128514.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.273 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATXN3NM_004993.6 linkc.891A>G p.Gln297Gln synonymous_variant Exon 10 of 11 ENST00000644486.2 NP_004984.2 P54252-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATXN3ENST00000644486.2 linkc.891A>G p.Gln297Gln synonymous_variant Exon 10 of 11 NM_004993.6 ENSP00000496695.1 P54252-2

Frequencies

GnomAD3 genomes
AF:
0.0343
AC:
686
AN:
20002
Hom.:
2
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.118
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0221
Gnomad ASJ
AF:
0.0128
Gnomad EAS
AF:
0.0167
Gnomad SAS
AF:
0.0156
Gnomad FIN
AF:
0.00542
Gnomad MID
AF:
0.0294
Gnomad NFE
AF:
0.0135
Gnomad OTH
AF:
0.0504
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.188
AC:
94896
AN:
503886
Hom.:
273
Cov.:
47
AF XY:
0.180
AC XY:
45777
AN XY:
254024
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.239
AC:
3383
AN:
14172
American (AMR)
AF:
0.151
AC:
2406
AN:
15940
Ashkenazi Jewish (ASJ)
AF:
0.143
AC:
1326
AN:
9274
East Asian (EAS)
AF:
0.0741
AC:
1604
AN:
21634
South Asian (SAS)
AF:
0.112
AC:
4929
AN:
43986
European-Finnish (FIN)
AF:
0.112
AC:
1957
AN:
17492
Middle Eastern (MID)
AF:
0.157
AC:
268
AN:
1702
European-Non Finnish (NFE)
AF:
0.210
AC:
75381
AN:
358210
Other (OTH)
AF:
0.170
AC:
3642
AN:
21476
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.385
Heterozygous variant carriers
0
4909
9819
14728
19638
24547
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3796
7592
11388
15184
18980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0344
AC:
689
AN:
20016
Hom.:
2
Cov.:
0
AF XY:
0.0358
AC XY:
365
AN XY:
10184
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.119
AC:
455
AN:
3838
American (AMR)
AF:
0.0220
AC:
35
AN:
1592
Ashkenazi Jewish (ASJ)
AF:
0.0128
AC:
6
AN:
470
East Asian (EAS)
AF:
0.0168
AC:
33
AN:
1968
South Asian (SAS)
AF:
0.0146
AC:
16
AN:
1094
European-Finnish (FIN)
AF:
0.00542
AC:
10
AN:
1846
Middle Eastern (MID)
AF:
0.0278
AC:
1
AN:
36
European-Non Finnish (NFE)
AF:
0.0135
AC:
119
AN:
8792
Other (OTH)
AF:
0.0543
AC:
14
AN:
258
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.326
Heterozygous variant carriers
0
59
117
176
234
293
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0375
Hom.:
77

ClinVar

Significance: Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 21, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Nov 12, 2014
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 22, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

ATXN3-related disorder Benign:1
Oct 31, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.42
DANN
Benign
0.29
PhyloP100
-0.27
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12896583; hg19: chr14-92537379; COSMIC: COSV61494112; API